90 related articles for article (PubMed ID: 15690871)
1. Low-dose levomepromazine in refractory emesis in advanced cancer patients: an open-label study.
Eisenchlas JH; Garrigue N; Junin M; De Simone GG
Palliat Med; 2005 Jan; 19(1):71-5. PubMed ID: 15690871
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous levomepromazine rescue (SLR) for high grade delayed chemotherapy-induced emesis (DCIE).
McCabe HL; Maraveyas A
Anticancer Res; 2003; 23(6D):5209-12. PubMed ID: 14981991
[TBL] [Abstract][Full Text] [Related]
3. The combination of levomepromazine (methotrimeprazine) and rotigotine enables the safe and effective management of refractory nausea and vomiting in a patient with idiopathic Parkinson's disease.
Hindmarsh J; Hindmarsh S; Lee M; Telford R
Palliat Med; 2019 Jan; 33(1):109-113. PubMed ID: 30404581
[TBL] [Abstract][Full Text] [Related]
4. An open study of methotrimeprazine in the management of nausea and vomiting in patients with advanced cancer.
Kennett A; Hardy J; Shah S; A'Hern R
Support Care Cancer; 2005 Sep; 13(9):715-21. PubMed ID: 15700129
[TBL] [Abstract][Full Text] [Related]
5. Levomepromazine for nausea and vomiting in advanced cancer.
Skinner J; Skinner A
Hosp Med; 1999 Aug; 60(8):568-70. PubMed ID: 10621811
[TBL] [Abstract][Full Text] [Related]
6. Levomepromazine for nausea and vomiting in palliative care.
Cox L; Darvill E; Dorman S
Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD009420. PubMed ID: 26524693
[TBL] [Abstract][Full Text] [Related]
7. [Improved antiemetic treatment with levomepromazine (author's transl)].
Higi M; Niederle N; Schmidt CG; Seeber S
Dtsch Med Wochenschr; 1980 May; 105(22):794-5. PubMed ID: 7190888
[TBL] [Abstract][Full Text] [Related]
8. Levomepromazine for nausea and vomiting in palliative care.
Darvill E; Dorman S; Perkins P
Cochrane Database Syst Rev; 2013 Apr; (4):CD009420. PubMed ID: 23633372
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the efficacy and safety of tropisetron, metoclopramide, and chlorpromazine in the treatment of emesis associated with far advanced cancer.
Mystakidou K; Befon S; Liossi C; Vlachos L
Cancer; 1998 Sep; 83(6):1214-23. PubMed ID: 9740088
[TBL] [Abstract][Full Text] [Related]
10. [Multi-drug antiemetic treatment and effect of treatment duration of concurrent steroids--for complete control of chemotherapy-induced nausea/vomiting in gynecological cancer].
Fujii T; Nakata N; Shiroyama Y; Sawasaki T; Tanimoto H; Shigemasa K; Kioka H; Naito H
Gan To Kagaku Ryoho; 1997 Dec; 24(15):2245-52. PubMed ID: 9422069
[TBL] [Abstract][Full Text] [Related]
11. [Effect of concurrent use of ondansetron hydrochloride and dexamethasone against nausea and vomiting in lung cancer patients receiving cisplatin].
Tanimura S; Banba J; Tomoyasu H; Masaki M
Gan To Kagaku Ryoho; 1998 Dec; 25(14):2275-81. PubMed ID: 9881085
[TBL] [Abstract][Full Text] [Related]
12. Methotrimeprazine versus haloperidol in palliative care patients with cancer-related nausea: a randomised, double-blind controlled trial.
Hardy JR; Skerman H; Philip J; Good P; Currow DC; Mitchell G; Yates P
BMJ Open; 2019 Sep; 9(9):e029942. PubMed ID: 31515428
[TBL] [Abstract][Full Text] [Related]
13. Granisetron vs dolasetron for acute chemotherapy-induced nausea and vomiting (CINV) in high and moderately high emetogenic chemotherapy: an open-label pilot study.
Tan M; Xu R; Seth R
Curr Med Res Opin; 2004 Jun; 20(6):879-82. PubMed ID: 15200746
[TBL] [Abstract][Full Text] [Related]
14. [Clinical efficacy of GG032X tablets, a new dosage form of ondansetron (fast dispersing tablet), on cisplatin-induced nausea and emesis].
Ariyoshi Y; Nukariya N; Akasaka Y; Suminaga M; Ota J; Ikeda M; Taguchi T
Gan To Kagaku Ryoho; 1997 Jun; 24(8):995-1011. PubMed ID: 9212810
[TBL] [Abstract][Full Text] [Related]
15. Olanzapine for the relief of nausea in patients with advanced cancer and incomplete bowel obstruction.
Kaneishi K; Kawabata M; Morita T
J Pain Symptom Manage; 2012 Oct; 44(4):604-7. PubMed ID: 22771132
[TBL] [Abstract][Full Text] [Related]
16. A case of transient myopia in a patient with multiple myeloma secondary to levomepromazine.
Kashani S; Barclay D; Lee E; Hollick E
Palliat Med; 2005 Apr; 19(3):261-2. PubMed ID: 15920942
[No Abstract] [Full Text] [Related]
17. [Evaluation of SN-307 (ondansetron), given intravenously for the treatment of nausea and vomiting caused by anticancer drugs including cisplatin-open study].
Ikeda M; Taguchi T; Ota K; Furue H; Niitani H; Tsukagoshi S; Ariyoshi Y; Akasaka Y; Ohta J; Suminaga M
Gan To Kagaku Ryoho; 1992 Sep; 19(11):1905-14. PubMed ID: 1387776
[TBL] [Abstract][Full Text] [Related]
18. A double-blind, randomised, parallel group, multinational, multicentre study comparing a single dose of ondansetron 24 mg p.o. with placebo and metoclopramide 10 mg t.d.s. p.o. in the treatment of opioid-induced nausea and emesis in cancer patients.
Hardy J; Daly S; McQuade B; Albertsson M; Chimontsi-Kypriou V; Stathopoulos P; Curtis P
Support Care Cancer; 2002 Apr; 10(3):231-6. PubMed ID: 11904788
[TBL] [Abstract][Full Text] [Related]
19. Low-dose mirtazapine may be successful treatment option for severe nausea and vomiting.
Pae CU
Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1143-5. PubMed ID: 16632163
[TBL] [Abstract][Full Text] [Related]
20. Antiemetic effect of ondansetron and dexamethasone in gynecologic malignant patients receiving chemotherapy.
Pradermdee P; Manusirivithaya S; Tangjitgamol S; Thavaramara T; Sukwattana P
J Med Assoc Thai; 2006 Oct; 89 Suppl 4():S29-36. PubMed ID: 17725140
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
